List of insiders holdings for Fresh Tracks Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| SINGER JAMES R 10% Owner | 2016-01-27 15:42:54 | 4,540,000 0 | 4,540,000 | Form 13G |
| V-Sciences Investments Pte Ltd Temasek Life Sciences Private LTD Fullerton Management Pte Ltd TEMASEK HOLDINGS (PRIVATE) LTD 10% Owner | 2009-06-12 16:29:52 | 2,920,224 0 | 2,920,224 | Form 13G |
| MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner | 2011-04-11 13:18:01 | 2,661,779 0 | 2,661,779 | Form 13G |
| AnGes MG Inc. 10% Owner | 2016-08-10 16:01:25 | 2,058,528 0 | 2,058,528 | Form 3 |
| Exploration Capital LLC 10% Owner | 2024-06-11 21:37:53 | 1,786,412 0 | 1,786,412 | Form 4 |
| CAMPBELL ROBERT H Director | 2012-11-28 16:12:30 | 1,631,676 26,000 | 1,657,676 | Form 4 |
| ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner | 2020-06-26 16:39:58 | 1,331,248 0 | 1,331,248 | Form 13G |
| Exploration Capital Fund LP Exploration Capital LLC Exploration Capital General Partner LLC 10% Owner | 2024-05-08 16:01:47 | 1,273,024 0 | 1,273,024 | Form 13D |
| Brown Robert Busard Chief Executive Officer | 2022-05-09 16:05:54 | 1,100,000 0 | 1,100,000 | Form 4 |
| Luchi Monica E. Chief Medical Officer | 2022-05-09 16:16:12 | 325,000 0 | 325,000 | Form 4 |
| ABERCROMBIE GEORGE B CHIEF EXECUTIVE OFFICER | 2020-02-19 17:07:09 | 84,477 131,194 | 215,671 | Form 4 |
| BILINSKY IGOR Sr VP, Corporate Development | 2015-07-15 16:49:35 | 193,798 0 | 193,798 | Form 4 |
| Breton Jose Chief Accounting Officer | 2022-05-09 16:17:30 | 150,000 0 | 150,000 | Form 4 |
| Broadfoot Jill Marie Sr Vice President, CFO, Sec | 2013-04-03 18:29:33 | 145,649 0 | 145,649 | Form 4 |
| Levy Adam Scott Chief Business Officer | 2020-03-18 16:30:15 | 131,364 0 | 131,364 | Form 4 |
| ROLLAND ALAIN P PHD Exec VP, Product Development | 2013-08-23 19:15:47 | 127,583 0 | 127,583 | Form 4 |
| Ahuja Sanjeev Chief Medical Officer | 2019-11-05 12:05:55 | 83,313 0 | 83,313 | Form 4 |
| Ju William Director | 2019-09-09 20:40:24 | 60,411 13,363 | 73,774 | Form 3 |
| SHERWIN STEPHEN A Director | 2015-05-26 13:25:16 | 72,003 0 | 72,003 | Form 4 |
| Mammen Mammen Sr VP, Clinical Development | 2018-01-10 11:29:35 | 70,000 0 | 70,000 | Form 4 |
| Ramos Anthony Alan VP, Chief Financial Officer | 2018-01-10 11:25:45 | 70,000 0 | 70,000 | Form 4 |
| VERU DENNISON T Director | 2022-05-17 17:14:13 | 65,000 0 | 65,000 | Form 4 |
| LYONS GARY A Director | 2022-05-17 17:15:05 | 65,000 0 | 65,000 | Form 4 |
| SAMANT VIJAY B Director | 2022-05-17 17:16:32 | 65,000 0 | 65,000 | Form 4 |
| HARDY REGINALD L CHAIRMAN OF THE BOARD | 2022-05-17 17:18:21 | 65,000 0 | 65,000 | Form 4 |
| SMITH LAWRENCE RUSSELL Sr VP, Research | 2018-01-10 11:05:57 | 60,000 0 | 60,000 | Form 4 |
| Carruthers R Michael Chief Financial Officer | 2020-03-18 16:30:27 | 55,808 0 | 55,808 | Form 4 |
| KASLOW DAVID C MD Chief Scientific Officer | 2006-02-23 17:24:19 | 43,405 0 | 43,405 | Form 4 |
| Sklawer Andrew D President and CEO | 2023-10-04 21:41:25 | 39,269 0 | 39,269 | Form 4 |
| Chadha Deepak Former Chief R&D Officer & COO | 2023-12-11 16:09:51 | 22,314 0 | 22,314 | Form 4 |
| McAvoy David R. Gen Counsel, CCO, & Secretary | 2023-10-04 21:40:24 | 16,061 310 | 16,371 | Form 4 |
| INGLE M BLAKE Director | 2005-05-19 16:40:24 | 12,500 0 | 12,500 | Form 4 |
| LATTERELL PATRICK F Director | 2003-05-22 17:03:37 | 12,500 0 | 12,500 | Form 4 |
| DEMSKI MARTHA J Vice President & CFO | 2004-05-24 14:28:31 | 8,000 0 | 8,000 | Form 4 |
| DOUGLAS R GORDON Director | 2018-05-24 11:28:53 | 8,000 0 | 8,000 | Form 4 |
| MERTON ROBERT C Director | 2018-05-24 11:40:01 | 6,500 0 | 6,500 | Form 4 |
| Beleson Richard M Director | 2018-05-24 11:36:11 | 6,500 0 | 6,500 | Form 4 |
| MORROW GEORGE J Director | 2018-05-24 11:33:04 | 6,500 0 | 6,500 | Form 4 |
| SHENK THOMAS E Director | 2018-05-24 11:26:48 | 6,500 0 | 6,500 | Form 4 |
| Marchio Albert N II CEO and CFO | 2024-01-09 16:10:04 | 0 0 | 0 | Form 4 |
| Fox-Collis Aaron VP of Finance & CAO | 2024-01-09 16:11:03 | 0 0 | 0 | Form 4 |